Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey L Greene

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Nature Communications|January 24, 2013
MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11Jessica Bockhorn, Rachel Dalton, Chika Nwachukwu, et al.
Science Translational Medicine|July 22, 2021
A small-molecule activator of the unfolded protein response eradicates human breast tumors in miceMatthew W Boudreau, Darjan Duraki, Lawrence Wang, et al.
Elife|November 30, 2018
The SERM/SERD bazedoxifene disrupts ESR1 helix 12 to overcome acquired hormone resistance in breast cancer cellsSean W Fanning, Rinath Jeselsohn, Venkatasubramanian Dharmarajan, et al.
EPJ Web of Conferences|December 1, 2022
Progress on the BL2 beam measurement of the neutron lifetimeShannon F Hoogerheide, Jimmy Caylor, Evan R Adamek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2018
Discovery of a Glucocorticoid Receptor (GR) Activity Signature Using Selective GR Antagonism in ER-Negative Breast CancerDiana C West, Masha Kocherginsky, Eva Y Tonsing-Carter, et al.
EMBO Molecular Medicine|September 13, 2014
The uterine and vascular actions of estetrol delineate a distinctive profile of estrogen receptor α modulation, uncoupling nuclear and membrane activationAnne Abot, Coralie Fontaine, Mélissa Buscato, et al.
Cell Reports|October 24, 2019
The Lineage Determining Factor GRHL2 Collaborates with FOXA1 to Establish a Targetable Pathway in Endocrine Therapy-Resistant Breast CancerKimberly J Cocce, Jeff S Jasper, Taylor K Desautels, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Nature Communications|January 24, 2013
MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11Jessica Bockhorn, Rachel Dalton, Chika Nwachukwu, et al.
Science Translational Medicine|July 22, 2021
A small-molecule activator of the unfolded protein response eradicates human breast tumors in miceMatthew W Boudreau, Darjan Duraki, Lawrence Wang, et al.
Elife|November 30, 2018
The SERM/SERD bazedoxifene disrupts ESR1 helix 12 to overcome acquired hormone resistance in breast cancer cellsSean W Fanning, Rinath Jeselsohn, Venkatasubramanian Dharmarajan, et al.
EPJ Web of Conferences|December 1, 2022
Progress on the BL2 beam measurement of the neutron lifetimeShannon F Hoogerheide, Jimmy Caylor, Evan R Adamek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2018
Discovery of a Glucocorticoid Receptor (GR) Activity Signature Using Selective GR Antagonism in ER-Negative Breast CancerDiana C West, Masha Kocherginsky, Eva Y Tonsing-Carter, et al.
EMBO Molecular Medicine|September 13, 2014
The uterine and vascular actions of estetrol delineate a distinctive profile of estrogen receptor α modulation, uncoupling nuclear and membrane activationAnne Abot, Coralie Fontaine, Mélissa Buscato, et al.
Cell Reports|October 24, 2019
The Lineage Determining Factor GRHL2 Collaborates with FOXA1 to Establish a Targetable Pathway in Endocrine Therapy-Resistant Breast CancerKimberly J Cocce, Jeff S Jasper, Taylor K Desautels, et al.
Pageof 8